LifeMD stockholders approve 3M share increase in 2020 equity plan; all director nominees elected

LifeMD, Inc.

Approved Third Amended and Restated 2020 Equity Plan, increasing share reserve by 3,000,000 shares (13,225,022 for, 8,347,423 against).
Elected nine directors; Justin Schreiber received highest votes (22,186,275 for), Roberto Simon lowest (15,381,405 for).
Non-binding advisory vote on executive compensation passed: 19,936,967 for, 2,250,462 against.
Ratified Marcum LLP as auditor for FY2024: 29,321,622 for, 288,475 against.
All four proposals passed at June 14, 2024 annual meeting; quorum of 29,831,868 shares present.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.